Mandatum Life Insurance Company’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-37,714
Closed -$515K – 93
2025
Q2
$515K Sell
37,714
-6,560
-15% -$92.5K 0.14% 55
2025
Q1
$680K Buy
44,274
+7,359
+20% +$115K 0.21% 50
2024
Q4
$564K Buy
36,915
+830
+2% +$13.3K 0.17% 53
2024
Q3
$589K Buy
36,085
+15,855
+78% +$272K 0.18% 48
2024
Q2
$381K Buy
20,230
+7,588
+60% +$147K 0.13% 58
2024
Q1
$249K Buy
+12,642
New +$255K 0.08% 69

Other funds holding OCSL

Mandatum Life Insurance Company's OCSL Position: Q3 2025 in Review

Mandatum Life Insurance Company sold out of Oaktree Specialty Lending (OCSL) in Q3 2025, closing a stake of 37,714 shares — an estimated $515K sold.

Mandatum Life Insurance Company first reported a position in OCSL in Q1 2024 and held it in 6 quarters. The position peaked at $680K in Q1 2025. 185 funds tracked by Wall St. Rank hold OCSL as of Q3 2025.

  • Mandatum Life Insurance Company reported no remaining Oaktree Specialty Lending position as of Q3 2025 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 37,714 Oaktree Specialty Lending shares in Q3 2025, an estimated $515K.
  • Mandatum Life Insurance Company first reported a position in Oaktree Specialty Lending in Q1 2024 and held it in 6 quarters.
  • Mandatum Life Insurance Company's Oaktree Specialty Lending position peaked at $680K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q3 2025.

Based on Mandatum Life Insurance Company's 13F filing for Q3 2025, filed 6 Nov 2025.